Scholarlink

<p>Comorbidity networks have become a valuable tool to support data-driven biomedical research. Yet, studies often are severely hindered by the availability of the necessary comprehensive data, often due to the sensitivity of health care information. This study presents a population-wide comorbidity network dataset derived from 45 million hospital stays of 8.9 million patients over 17 years in Austria. We present co-occurrence networks of hospital diagnoses, stratified by age, sex, and observation period in a total of 96 different subgroups. For each of these groups we report a range of association measures (e.g., count data, and odds ratios) for all pairs of diagnoses. The dataset provides the possibility to researchers to create their own, tailor-made comorbidity networks from real patient data that can be used as a starting point in quantitative and machine learning methods. This data platform is intended to lead to deeper insights into a wide range of epidemiological, public health, and biomedical research questions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comorbidity Networks From Population-Wide Health Data: Aggregated Data of 8.9M Hospital Patients (1997–2014)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月5日

查看全文
  • Elma Dervić,
  • Katharina Ledebur,
  • Stefan Thurner,
  • Peter Klimek

摘要

Comorbidity networks have become a valuable tool to support data-driven biomedical research. Yet, studies often are severely hindered by the availability of the necessary comprehensive data, often due to the sensitivity of health care information. This study presents a population-wide comorbidity network dataset derived from 45 million hospital stays of 8.9 million patients over 17 years in Austria. We present co-occurrence networks of hospital diagnoses, stratified by age, sex, and observation period in a total of 96 different subgroups. For each of these groups we report a range of association measures (e.g., count data, and odds ratios) for all pairs of diagnoses. The dataset provides the possibility to researchers to create their own, tailor-made comorbidity networks from real patient data that can be used as a starting point in quantitative and machine learning methods. This data platform is intended to lead to deeper insights into a wide range of epidemiological, public health, and biomedical research questions.